| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | saframycin D Basic information |
| Product Name: | saframycin D | | Synonyms: | saframycin D;N-[[(6R)-6,7,9,10,13,14,14aα,15-Octahydro-1,4-dihydroxy-2,11-dimethoxy-3,12,16-trimethyl-5,10,13-trioxo-6α,15α-epimino-5H-isoquino[3,2-b][3]benzazocin-9β-yl]methyl]-2-oxopropionamide;Propanamide, N-[[(6R,9R,14aS,15R)-6,7,9,10,13,14,14a,15-octahydro-1,4-dihydroxy-2,11-dimethoxy-3,12,16-trimethyl-5,10,13-trioxo-6,15-imino-5H-isoquino[3,2-b][3]benzazocin-9-yl]methyl]-2-oxo- | | CAS: | 66082-30-2 | | MF: | C28H31N3O9 | | MW: | 553.56 | | EINECS: | | | Product Categories: | | | Mol File: | 66082-30-2.mol |  |
| | saframycin D Chemical Properties |
| density | 1.49±0.1 g/cm3(Predicted) | | pka | 8.11±0.70(Predicted) |
| | saframycin D Usage And Synthesis |
| Uses | Saframycin D has the effect of anti-Gram-positive bacteria. Saframycin D also has weak activity against mycobacteria[1]. | | References | [1] A Kubo, et al. Structure of saframycin D, a new dimeric isoquinolinequinone antibiotic. Chem Pharm Bull (Tokyo). 1987 Jan;35(1):440-2. |
| | saframycin D Preparation Products And Raw materials |
|